Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 15/20 | 0.47 |
| ▸ | FNTB | P49356 | 15/20 | 0.47 |
| ▸ | PGGT1B | P53609 | 13/20 | 0.47 |
| ▸ | NPY4R | P50391 | 5/20 | 0.43 |
| ▸ | NPY1R | P25929 | 4/20 | 0.43 |
| ▸ | NPY2R | P49146 | 3/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30173871 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30173822 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30173933 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30173943 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30463241 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30173868 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30173879 | 1.00 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30463242 | 0.99 | FNTA (0.48) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL30173876 | 0.99 | FNTA (0.48) | FNTAFNTBPGGT1BNPY4RNPY1R | |
| SCHEMBL31157769 | 0.98 | FNTA (0.47) | FNTAFNTBPGGT1BNPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-06-22 | — | — | US | claimed |
| EP-4362904-A1 | COSMETIC, NON-THERAPEUTIC USES OF PEPTIDES | Lubrizol Advanced Materials, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023275811-A1 | COSMETIC, NON-THERAPEUTIC USES OF PEPTIDES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | GLA, ALG3, ANXA6 | FNTA 3091/4885FNTB 4413/4885PGGT1B 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.